Human CX3CL1/Fractalkine Chemokine Domain Antibody, R&D Systems™

CX3CL1/Fractalkine

Polyclonal

Western Blot 0.1 ug/mL, Neutralization 0.3-1.5 ug/mL

Q6I9S9

CX3CL1

E. coli-derived recombinant human CX3CL1/Fractalkine Gln25-Gly100 Accession # Q6I9S9

25 μg

Primary

Detects human CX3CL1/Fractalkine in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant human (rh) MCP-2 and rhMCP-4 is observed.

Human

IgG

Western Blot, Neutralization

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

ABCD-3, C3Xkine, chemokine (C-X3-C motif) ligand 1, CX3C membrane-anchored chemokine, CXC3, CXC3C, FKN, fractalkine, Neurotactin, neurotactin), NTNsmall inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, NTTSmall-inducible cytokine D1, SCYD1C-X3-C motif chemokine 1, small inducible cytokine subfamily D (Cys-X3-Cys), member-1

Goat

Affinity Purified

RUO

6376

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.